Research Methodologies Followed:

Secondary Research:

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Sleep Apnea Devices Market. The secondary sources used for this study include American Academy of Sleep Medicine (AASM), American Association of Sleep Technologists (AAST), American Sleep Apnea Association (ASAA), American Board of Dental Sleep Medicine (ABDSM), National Center for Biotechnology Information (NCBI), National Institute for Health and Care Excellence (NICE), National Institutes of Health (NIH), Canadian Sleep Society (CSS), Canadian Society of Respiratory Therapists (CSRT), Canadian Sleep Circadian Network, and British Lung Foundation (BLF).

Primary Research:

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Major Growth Driving Factors:

Market growth is mainly driven by factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

Global Key Players:

The global sleep apnea devices market is highly consolidated. The prominent players operating in this market include ResMed (US), Koninklijke Philips N.V. (Netherlands) and Fisher Paykel Healthcare (New Zealand).

ResMed (US) is one of the leading players in the sleep apnea devices market. The company operates its Total Sleep and Respiratory Care segment through two business segments, namely Devices and Masks and other. The company has a widespread presence globally in over North America, Latin America, Asia Pacific, and other markets. The company has a diverse product portfolio for sleep apnea disorders and offers various devices and accessories.

Koninklijke Philips N.V. (Netherlands) is one of the leading players in the sleep apnea devices market. The leading position can be attributed to its diversified product portfolio and wide geographical presence in North America, Europe, the Asia Pacific, and Africa.

Fisher Paykel Healthcare (New Zealand) held the third position in the sleep apnea devices market in 2020. The company has geographical presence in the New Zealand, Australia, the US, Germany, France, Sweden, Italy, Hong Kong, India, and Mexico.

Recent Developments:

# In June 2021, Oventus Medical signed a partnership agreement with Aeroflow Healthcare to provide Oventus’ obstructive sleep apnea (OSA) treatment solutions, including O2Vent Optima, directly to consumers via sleep clinics in the US.

# In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy in the US through GoPAPfree.

# In November 2020, Panthera Dental collaborated with Dentsply Sirona.

# In December 2019, Fisher Paykel Healthcare signed a USD-1.5-million partnership agreement with Counties Manukau Health (CM Health) to provide funding for clinical research at Middlemore Hospital.

# In March 2019, ResMed acquired HB Healthcare, a home medical equipment provider, which offers sleep and respiratory care devices.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

North America was the largest regional market for sleep apnea devices market in 2020.

The sleep apnea devices market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America was the largest regional segment of the overall market, followed by Europe. The large share of North American can be attributed to the increasing prevalence of the sleep apnea, growing awareness, wide usage of oral appliances for sleep apnea and the of the leading players, such as ResMed, and Inspire Medical Systems, Inc., in the region.